Prior to joining Ardan Equity, Mike was the CEO of Mach7 Technologies. Mach7 Technologies delivers an intelligent enterprise software workflow platform that unlocks disparate silos, consolidates patient data, and simplifies sharing and access.
Prior to Mach7, Mike was the Americas Region CEO HCIT at GE Healthcare, Mike operated as the business leader responsible for the Americas GE Healthcare Digital business. While at GE Mike was also the CEO of the Enterprise Imaging and Specialty Solutions, a $1 Billion business, which includes PACS, RIS, VNA, Advance Visualization, Cardiology, Perinatal, Peri-operative and Digital Pathology. Specific to digital pathology, Mike oversaw GE’s digital pathology Omnyx partnership with UPMC, and understood firsthand the challenges of pathology labs in going digital, and how current technologies were not meeting lab requirements.
Formerly, Mr. Jackman served as President of Healthcare Information Solutions for Carestream Health, Inc., the independent company that resulted from the sale of Eastman Kodak Company’s Health Group to Onex Corporation, Toronto, Canada, in May 2007.
Mr. Jackman served Kodak’s Health Group as General Manager, Healthcare Information Solutions; and in May 2005, Kodak’s Board of Directors elected him a Corporate Officer and Vice President of Eastman Kodak Company. Mr. Jackman joined Kodak in 2003 to lead global research and development operations for the Health Group.
During a successful 18-year career at IBM, Mr. Jackman served in several senior management positions, including Vice President, Systems and Technology. In this capacity, he was responsible for integrated product solutions, technology strategy, strategic alliances, engineering services and intellectual property licensing strategy. He also led worldwide business operations for IBM’s ThinkPad line and served as Technology Advisor to IBM’s Chairman and CEO.
Mr. Jackman earned a B.S. degree in electrical engineering from the University of Rhode Island and an M.B.A. from Nova University.
Mike was introduced to Augmentiqs via the Luminate Accelerator, the world’s largest optics accelerator located in Rochester NY, and under the auspices of the Empire State Development Fund.